Northern Trust’s Thorne Healthtech, Inc. Common Stock THRN Stock Holding History

Northern Trust’s Portfolio THRN Stock Details THRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-116,661	Closed	-$1.19M	–	4620
2023 Q3	$1.19M	Buy	116,661 +3,922	+3%	+$29.9K	﹤0.01%	3226
2023 Q2	$530K	Buy	112,739 +1,535	+1%	+$7.05K	﹤0.01%	3531
2023 Q1	$514K	Buy	111,204 +6,226	+6%	+$27.4K	﹤0.01%	3463
2022 Q4	$381K	Sell	104,978 -2,221	-2%	-$9.85K	﹤0.01%	3592
2022 Q3	$507K	Buy	107,199 +5,132	+5%	+$25.8K	﹤0.01%	3504
2022 Q2	$494K	Buy	102,067 +43,592	+75%	+$265K	﹤0.01%	3540
2022 Q1	$372K	Sell	58,475 -9,098	-13%	-$49K	﹤0.01%	3854
2021 Q4	$420K	Buy	+67,573	New	+$528K	﹤0.01%	3874

Northern Trust's THRN Position: Q4 2023 in Review

Northern Trust sold out of Thorne Healthtech, Inc. Common Stock (THRN) in Q4 2023, closing a stake of 116,661 shares — an estimated $1.19M sold.

Northern Trust first reported a position in THRN in Q4 2021 and held it in 8 quarters. The position peaked at $1.19M in Q3 2023. 0 funds tracked by Wall St. Rank hold THRN as of Q4 2023.

Northern Trust reported no remaining Thorne Healthtech, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Northern Trust sold 116,661 Thorne Healthtech, Inc. Common Stock shares in Q4 2023, an estimated $1.19M.
Northern Trust first reported a position in Thorne Healthtech, Inc. Common Stock in Q4 2021 and held it in 8 quarters.
Northern Trust's Thorne Healthtech, Inc. Common Stock position peaked at $1.19M in Q3 2023.
0 funds tracked by Wall St. Rank held Thorne Healthtech, Inc. Common Stock as of Q4 2023.

Based on Northern Trust's 13F filing for Q4 2023, filed 13 Feb 2024.